All Stories

  1. Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study

    Article • Frontiers in Oncology, November 2023, Frontiers

    Dr Jeffrey Tuan

  2. Predicting dice similarity coefficient of deformably registered contours using Siamese neural network

    Article • Physics in Medicine and Biology, July 2023, Institute of Physics Publishing

    Dr Jeffrey Tuan

  3. Far from the truth: Real‐world treatment patterns among newly diagnosed metastatic prostate cancer in the era of treatment intensification

    Article • International Journal of Urology, July 2023, Wiley

    Dr Jeffrey Tuan

  4. Minimum data elements for the Australian Particle Therapy Clinical Quality Registry

    Article • Journal of Medical Imaging and Radiation Oncology, July 2023, Wiley

    Dr Jeffrey Tuan

  5. Patient‐reported functional outcomes and oncological control after primary focal cryotherapy for clinically significant prostate cancer: A Phase II mandatory biopsy‐monitored study

    Article • The Prostate, March 2023, Wiley

    Dr Jeffrey Tuan

  6. Management of Acute Cancer Pain in Asia: An Expert Opinion on the Role of Tramadol/Dexketoprofen Fixed-Dose Combination

    Article • Cureus, March 2023, Springer Science + Business Media

    Dr Jeffrey Tuan

  7. A Review of the Current Clinical Evidence for Loco-Regional Moderate Hyperthermia in the Adjunct Management of Cancers

    Article • Cancers, January 2023, MDPI AG

    Dr Jeffrey Tuan

  8. Predictors for late genitourinary toxicity in men receiving radiotherapy for high-risk prostate cancer using planned and accumulated dose

    Article • Physics and Imaging in Radiation Oncology, January 2023, Elsevier

    Dr Jeffrey Tuan

  9. Oncologic outcomes after MRI-assisted image-guided brachytherapy with hybrid interstitial and intra-cavitary applicators under moderate sedation for locally advanced cervix cancer

    Article • Journal of Contemporary Brachytherapy, January 2023, Termedia Sp. z.o.o.

    Dr Jeffrey Tuan

  10. Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose

    Article • Frontiers in Oncology, December 2022, Frontiers

    Dr Jeffrey Tuan

  11. Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate cancer

    Article • Physics and Imaging in Radiation Oncology, July 2022, Elsevier

    Dr Jeffrey Tuan

  12. Cardiovascular toxicities of androgen deprivation therapy in Asian men with localized prostate cancer after curative radiotherapy: a registry-based observational study

    Article • Cardio-Oncology, March 2022, Springer Science + Business Media

    Dr Jeffrey Tuan

  13. Evaluation of inter- and intra-observer variations in prostate gland delineation using CT-alone versus CT/TPUS

    Article • Reports of Practical Oncology & Radiotherapy, March 2022, VM Media SP. zo.o VM Group SK

    Dr Jeffrey Tuan

  14. Comparative genomic analyses between Asian and Caucasian prostate cancers in an 80,829 patient cohort.

    Article • Journal of Clinical Oncology, February 2022, American Society of Clinical Oncology (ASCO)

    Dr Jeffrey Tuan

  15. Application of an automated dose accumulation workflow in high-risk prostate cancer - validation and dose-volume analysis between planned and delivered dose

    Article • Medical Dosimetry, January 2022, Elsevier

    Dr Jeffrey Tuan

  16. Efficacy, toxicity, and quality‐of‐life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single‐arm phase 2 trial from Asia

    Article • Asia-Pacific Journal of Clinical Oncology, December 2021, Wiley

    Dr Jeffrey Tuan

  17. Serum testosterone levels and testosterone ‘bounce’ phenomenon predict response to novel anti-androgen therapies in castration-resistant prostate cancer

    Article • Urologic Oncology Seminars and Original Investigations, December 2021, Elsevier

    Dr Jeffrey Tuan

  18. Investigation of a 22-gene genomic classifier (GC) for risk stratification and molecular subtyping in an Asian prostate cancer (PCa) cohort.

    Article • Journal of Clinical Oncology, February 2021, American Society of Clinical Oncology (ASCO)

    Dr Jeffrey Tuan

  19. Palliative radiotherapy for bladder cancer: a systematic review and meta-analysis

    Article • Acta Oncologica, February 2021, Acta Dermato-Venereologica

    Dr Jeffrey Tuan

  20. A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation Therapy Planning-A Retrospective Multicenter Study

    Article • Diagnostics, November 2020, MDPI AG

    Dr Jeffrey Tuan

  21. 218MO Comparison of a 22-gene genomic classifier (GC) with NCCN for risk stratification of Asian prostate cancers (PCa)

    Article • Annals of Oncology, November 2020, Elsevier

    Dr Jeffrey Tuan

  22. Understanding the Psychological Impact of COVID-19 Pandemic on Patients With Cancer, Their Caregivers, and Health Care Workers in Singapore

    Article • JCO Global Oncology, November 2020, American Society of Clinical Oncology (ASCO)

    Dr Jeffrey Tuan

  23. Development of an automated radiotherapy dose accumulation workflow for locally advanced high‐risk prostate cancer – A technical report

    Article • Journal of Medical Radiation Sciences, October 2020, Wiley

    Dr Jeffrey Tuan

  24. Technical considerations for positioning and placement of a transperineal ultrasound probe during prostate radiotherapy

    Article • Journal of Medical Radiation Sciences, October 2020, Wiley

    Dr Jeffrey Tuan

  25. Managing the COVID-19 Pandemic as a National Radiation Oncology Centre in Singapore

    Article • Clinical Oncology, July 2020, Elsevier

    Dr Jeffrey Tuan

  26. Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore

    Article • Radiotherapy and Oncology, July 2020, Elsevier

    Dr Jeffrey Tuan

  27. Dosimetric comparison of RapidPlan and manually optimised volumetric modulated arc therapy plans in prostate cancer

    Article • Journal of Radiotherapy in Practice, May 2020, Cambridge University Press

    Dr Jeffrey Tuan

  28. Preliminary outcomes of a prospective observational study of combinatorial abiraterone acetate/enzalutamide (AA/Enz) and radical radiotherapy (RT) in nonmetastatic node-positive (N+M0) prostate cancer (PCa).

    Article • Journal of Clinical Oncology, February 2020, American Society of Clinical Oncology (ASCO)

    Dr Jeffrey Tuan

  29. Duration-dependent margins for prostate radiotherapy—a practical motion mitigation strategy

    Article • Strahlentherapie und Onkologie, January 2020, Springer Science + Business Media

    Dr Jeffrey Tuan

  30. Estimation of Duration-Dependent Margins for Prostate Radiotherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2019, Elsevier

    Dr Jeffrey Tuan

  31. PO-1122 Assessment of bladder volume and urinary symptoms for patients undergoing prostate radiotherapy.

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr Jeffrey Tuan

  32. EP-1547 Developing an empirical nomogram for clinical visualization of DFS/OS for prostate cancer patients

    Article • Radiotherapy and Oncology, April 2019, Elsevier

    Dr Jeffrey Tuan

  33. Clinical and genetic determinants of toxicity and quality-of-life (QOL) outcomes for SBRT in Asian prostate cancer.

    Article • Journal of Clinical Oncology, March 2019, American Society of Clinical Oncology (ASCO)

    Dr Jeffrey Tuan

  34. 68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy

    Article • Cancer Biology and Medicine, January 2019, Cancer Biology and Medicine

    Dr Jeffrey Tuan

  35. EP-1559: Quality of Life Results of a Phase II Study of SBRT for Prostate Cancer in an Asian population

    Article • Radiotherapy and Oncology, April 2018, Elsevier

    Dr Jeffrey Tuan

  36. Reduction of intra-fraction prostate motion – Determining optimal bladder volume and filling for prostate radiotherapy using daily 4D TPUS and CBCT

    Article • Technical Innovations & Patient Support in Radiation Oncology, March 2018, Elsevier

    Dr Jeffrey Tuan

  37. 68-Ga prostate-specific membrane antigen-PET as a diagnostic and clinical decision making tool in biochemical recurrences post-radical prostatectomy.

    Article • Journal of Clinical Oncology, February 2018, American Society of Clinical Oncology (ASCO)

    Dr Jeffrey Tuan

  38. Analysis of intra-fraction prostate motion and derivation of duration-dependent margins for radiotherapy using real-time 4D ultrasound

    Article • Physics and Imaging in Radiation Oncology, January 2018, Elsevier

    Dr Jeffrey Tuan

  39. OC-0165: TPUS vs CBCT: comparison of daily inter-modality derived setup shifts for prostate radiotherapy

    Article • Radiotherapy and Oncology, May 2017, Elsevier

    Dr Jeffrey Tuan

  40. A comparison of interfraction setup error, patient comfort, and therapist acceptance for 2 different prostate radiation therapy immobilization devices

    Article • Advances in Radiation Oncology, April 2017, Elsevier

    Dr Jeffrey Tuan

  41. Inter- and intra-observer variation of patient setup shifts derived using the 4D TPUS Clarity system for prostate radiotherapy

    Article • Biomedical Physics & Engineering Express, March 2017, Institute of Physics Publishing

    Dr Jeffrey Tuan

  42. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

    Article • Medicine, February 2016, Wolters Kluwer Health

    Dr Jeffrey Tuan

  43. Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients

    Article • Oncotarget, May 2015, Impact Journals, LLC

    Dr Jeffrey Tuan

  44. Estimating Cardiac Substructures Exposure From Diverse Radiotherapy Techniques in Treating Left-Sided Breast Cancer

    Article • Medicine, May 2015, Wolters Kluwer Health

    Dr Jeffrey Tuan

  45. Radiation therapy for retroperitoneal sarcoma

    Article • La radiologia medica, March 2014, Springer Science + Business Media

    Dr Jeffrey Tuan

  46. Prognostic significance of blood transfusion and anaemia on survival in stage IIIA/B/C and IVA oesophageal cancers treated with chemoradiotherapy

    Article • Journal of Radiation Oncology, March 2014, Springer Science + Business Media

    Dr Jeffrey Tuan

  47. Proton beam radiotherapy: report of the first ten patients treated at the “Centro Nazionale di Adroterapia Oncologica (CNAO)” for skull base and spine tumours

    Article • La radiologia medica, December 2013, Springer Science + Business Media

    Dr Jeffrey Tuan

  48. Position statement on ethics, equipoise and research on charged particle radiation therapy

    Article • Journal of Medical Ethics, September 2013, BMJ

    Dr Jeffrey Tuan

  49. Initial clinical experience with scanned proton beams at the Italian National Center for Hadrontherapy (CNAO)

    Article • Journal of Radiation Research, July 2013, Oxford University Press (OUP)

    Dr Jeffrey Tuan

  50. Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy

    Article • Journal of Radiation Research, July 2013, Oxford University Press (OUP)

    Dr Jeffrey Tuan

  51. Analysis in early stage triple‐negative breast cancer treated with mastectomy without adjuvant radiotherapy: Patterns of failure and prognostic factors

    Article • Cancer, April 2013, Wiley

    Dr Jeffrey Tuan

  52. Outcomes of Intensity-modulated Radiotherapy for Prostate Cancer using an Empty Bladder Protocol

    Article • Clinical Oncology, November 2012, Elsevier

    Dr Jeffrey Tuan

  53. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma

    Article • Radiotherapy and Oncology, September 2012, Elsevier

    Dr Jeffrey Tuan

  54. Effect of Anaemia Prevention on Survival and Local Control in Oesophageal Cancers Treated with Chemoradiotherapy

    Article • Clinical Oncology, August 2012, Elsevier

    Dr Jeffrey Tuan

  55. Basaloid carcinoma of the prostate: A literature review with case report

    Article • Indian Journal of Urology, January 2012, Medknow

    Dr Jeffrey Tuan

  56. 7040 POSTER Treatment of Prostate Cancer With Intensity Modulated Radiation Therapy Using an Empty Bladder Protocol – Treatment Outcomes and Toxicity Profile

    Article • European Journal of Cancer, September 2011, Elsevier

    Dr Jeffrey Tuan

  57. HER2-neu Positivity Prognosticates for Poor Disease Control in Asian Women with Small, Node Negative Breast Cancer Treated with Conservation Therapy

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2010, Elsevier

    Dr Jeffrey Tuan

  58. Retropharyngeal nodal metastasis related to higher rate of distant metastasis in patients with N0and N1nasopharyngeal cancer

    Article • Head & Neck, April 2009, Wiley

    Dr Jeffrey Tuan

  59. Radical radiotherapy with high‐dose‐rate brachytherapy for uterine cervix cancer long‐term results†

    Article • Australasian Radiology, October 2007, Wiley

    Dr Jeffrey Tuan

  60. 5525 POSTER Retropharyngeal nodal metastasis is related to a higher rate of distant metastasis in patients with nasopharyngeal cancer – results from a single centre retrospective study

    Article • European Journal of Cancer Supplements, September 2007, Elsevier

    Dr Jeffrey Tuan

  61. Do Elderly Patients with Cervical Cancer Fare Worse with Radiotherapy Compared to Their Younger Counterparts?

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2005, Elsevier

    Dr Jeffrey Tuan